Documente Academic
Documente Profesional
Documente Cultură
reprints@futuremedicine.com
S PECIAL R EPORT
for correspondence
School of Public
Health, Channing
Laboratory, Department of
Medicine, Brigham and
Womens Hospital, Harvard
Medical School and
Department of Epidemiology,
Boston, MA, USA
2Harvard School of Public
Health, Channing Lab, 181
Longwood Avenue, Boston,
MA, USA
Tel.: +1 617 525 2279;
Fax: +1 617 525 2008;
E-mail: fran.grodstein
@channing.harvard.edu
1Harvard
Keywords: Alzheimers
disease, antioxidants,
-carotene, cognitive decline,
dementia, vitamin C,
vitamin E
part of
Biology
The free-radical hypothesis of aging was first
proposed in 1956 [5]. The theory, which is now
supported by numerous experiments and observations, suggests that free radicals or oxidants
produced by the body have deleterious, systemic
effects [69]. In particular, brain tissue is a site of
high metabolic activity in which free radicals
(oxygen molecules with unpaired electrons) are
generated. Those oxygen molecules are highly
reactive and cause damage to the surrounding
tissue. Oxidative stress likely acts through additional pathways as well. A recent study indicated
the wide possible variety of mechanisms that
may be involved [10]. In a study of vitamin Edeficient and normally fed rats, gene expression
was explored in the hippocampus; vitamin E
deficiency had a strong impact on genes associated with hormones and hormone metabolism,
nerve growth factor, apoptosis, dopaminergic
neurotransmission and the clearance of amyloid- and advanced glycated end products. In
particular, vitamin E deficiency strongly
affected the expression of an array of genes
encoding proteins directly or indirectly involved
in the clearance of amyloid-.
Indeed, the role of antioxidant vitamins in
protecting against amyloid--induced damage
has been extensively explored. Amyloid-
plaques are one of the neuropathological hallmarks of AD and play a major role in its pathogenesis [11,12]. In transgenic mice, Sung and
colleagues found that vitamin E supplementation in young (5-month-old), but not old
(14-month-old) mice, reduced the level of amyloid- deposition (p < 0.01) [13]. This further
suggests that antioxidant supplementation may
Aging Health (2007) 3(1), 2332
23
Table 1. Antioxidant sources, recommended daily values and mean intakes in the USA.
Food sources
Vitamin E
30 International units
Vitamin C
75 mg (adult women)
90 mg (adult men)
-carotene
Subjects
Outcome
5092
Incident AD
Vitamin E + C:
RR: 0.36; 95% CI: 0.090.99
Ref.
[23]
894
Cognitive decline,
incident dementia
and AD
[24]
616
Incident dementia
and AD
[25]
14,968
Cognitive
performance
Vitamin E + vitamin C:
mean difference in global score, p = 0.07
Long-term (10 years) vitamin E + C:
mean difference in global score, p = 0.03
[26]
3385
Incident dementia
and cognitive
performance
Vitamin E + C, AD:
RR: 0.55; 95% CI: 0.281.10
Long-term (10+ years) vitamin E + C, cognitive decline:
RR: 0.57; 95% CI: 0.420.79
[27]
AD: Alzheimers disease; CI: Confidence interval; OR: Odds ratio; RR: Relative risk.
www.futuremedicine.com
25
(p = 0.07). However, significantly better performance was found specifically for the longestterm users of vitamin E with C, compared with
nonusers (for >10 years of use; p = 0.03).
Similarly, in the HonoluluAsia Aging Study
(HAAS), which explored both dementia and cognitive function among 3385 older men, the overall data on antioxidant supplements and cognitive
outcomes were weak [27]. There was no statistically
significant relationship observed between antioxidant supplements and AD (RR: 0.55; 95%
CI: 0.281.10). However, the HAAS reported
similar results to the Nurses Health Study, in that
long-term users (10 years) of vitamin E with
vitamin C had 43% lower odds (RR: 0.57;
95% CI: 0.420.79) of poor cognitive performance on the Cognitive Abilities Screening Instrument, as compared with participants who
reported no use of these supplements.
Summary
Subjects
Outcome
Results
Rotterdam Study
5395
Incident AD
[29]
2889
Cognitive decline
[30]
815
Incident AD
[31]
1041
Incident AD and
cognitive decline
[35]
Paquid Cohort
1367
Incident dementia
[32]
980
Incident AD
[33]
HonoluluAsia Aging
Study
2459
Incident dementia
[27]
*Data
Ref.
given as regression coefficients x 102 standard units. AD: Alzheimers disease; CI: Confidence interval; RR: Relative risk.
www.futuremedicine.com
statistical significance. However, in this innercity population, relatively low levels of antioxidants vitamins were consumed; for instance, the
highest category of vitamin E intake
(mean: 7 IU/day) in this study was similar to
the
lowest
category
in
CHAP
(mean: 6.8 IU/day), thus it may be difficult to
compare the findings from WHICAP to those
of other studies with different populations. In
the HAAS cohort, no relationship was found
between midlife intake of vitamin E (RR: 1.33;
95% CI: 0.901.96), vitamin C (RR: 1.25;
95% CI: 0.871.78) or -carotene (RR: 1.08;
95% CI: 0.741.57) and risk of late-life dementia, comparing the highest to lowest quartiles
[34]. However, this study had fairly high loss to
follow-up (29.9%) and utilized a single 24-h
dietary recall to represent long-term antioxidant
intake, both of which may result in particularly
diminished ability to detect associations.
27
Finally, to explore whether any possible differences in the effect of supplements and the
effect of dietary vitamin E may be attributable
to their different tocopherol forms, one study
specifically examined the four tocopherol
forms in relation to AD and cognitive decline
[35]. The investigators found that a reduced risk
of AD was associated with a higher dietary
intake of vitamin E (RR: 0.74 for every
5 mg/day
increase
in
intake;
95%
CI: 0.620.88) and -tocopherol equivalents
(RR: 0.56 for every 5 mg/day increase; 95%
CI: 0.32, 0.98). In addition, a slower rate of
cognitive decline was associated with intakes of
vitamin E, -tocopherol equivalents, and and -tocopherols. Therefore, it appears that a
combined intake of the tocopherol forms, not
just the -tocopherol found in supplements,
may be important in providing protection
against AD and cognitive decline.
Summary
Overall, there are relatively few studies of dietary antioxidant vitamins and cognitive function or dementia. But the limited evidence
may suggest that dietary vitamin E could specifically have the potential to reduce the risk of
dementia or cognitive impairment. However,
there are insufficient data to make any firm
conclusions, and it could also be possible that
the studies of dietary vitamin E simply better
represent long-term intake than studies of supplement use, since diet generally does not
change substantially over time, but supplement use can be more sporadic over time. This
is clearly an area that needs substantial
additional research.
Randomized clinical trials
Subjects
Outcome
Duration of
study
Ref.
Alzheimers Disease
Cooperative Study
769
3 years
[36]
Alzheimers Disease
Cooperative Study
341 with
moderately
severe AD
2 years
Cognitive decline:
No relations observed
Median time to disease progression:
Placebo: 440 days
Selegiline (10 mg/day): 655 days,
p = 0.012
Selegiline (10 mg/day) + vitamin E
(2000 IU/day): 670 days, p = 0.001
Vitamin E (2000 IU/day): 585 days,
p = 0.049
[37]
Age-Related Eye
Disease Study
2166
Cognitive performance,
modified MMSE
6.9 years
[38]
MRC/BHF Heart
Protection Study
20,536
5 years
[39]
Womens Health
Study
6377
510 years
[40]
Physicians Health
Study II
5956
Cognitive performance,
summary score across battery of
cognitive tests
Long-term
(mean 18 years)
Short-term
(mean 1 year)
[41]
*Vitamin E 600 mg = 900 IU of Vitamin E. AD: Alzheimers disease; BHF: British Heart Foundation; CI: Confidence interval; IU: International unit(s);
MMSE: Mini-mental state exam; MRC: Medical Research Council; RR: Relative risk; TICS: Telephone interview of cognitive status.
www.futuremedicine.com
Conclusion
Despite strong biological evidence supporting a
role for antioxidant treatment in the prevention
of brain aging, overall, the epidemiological evidence regarding possible benefits of antioxidants on cognitive function are inconsistent,
and largely unconvincing. Most of the observational studies, even the larger studies, have
somewhat limited statistical power, and their
results are fairly unstable. Very limited data suggest that dietary antioxidants, especially vitamin E, might have greater potential to decrease
risk of cognitive impairment than antioxidant
supplements, but this area needs substantially
more investigation before any conclusions or
recommendations can be made. However,
growing data, including randomized clinical
trials, indicate that the duration of exposure
might be a critical factor in neuroprotection,
with long-term, but not shorter-term, antioxidant intake holding the greatest promise for
Executive summary
Introduction
Alzheimers disease, dementia and general cognitive decline are significant public health issues. Antioxidant vitamins may provide
a means for delaying or preventing these conditions.
Biology
Animal and cell culture studies suggest that antioxidants, such as vitamin E, prevent oxidative damage, which may play a role in
brain aging and cognitive impairment.
Animal data indicate that long-term exposure to antioxidants may be required to provide neuroprotection.
Observational epidemiological studies of antioxidant supplements
Several large-scale, prospective studies have examined the relationship between antioxidant supplements and cognitive decline or
dementia. Results are largely null, with positive findings tending to be statistically unstable.
Limited studies of long-term intake of supplements suggest that at least 10 years of supplementation with vitamins E and C
combined could reduce cognitive impairment and dementia.
Observational epidemiological studies of antioxidant vitamins in diet
There are very limited studies examining dietary intake of antioxidants and cognitive impairment. Two studies suggest that dietary
vitamin E may have the potential to decrease risk of cognitive decline and dementia, but this area needs significantly more
research attention, in particular regarding the various forms of vitamin E that are available in foods.
Randomized clinical trials of antioxidant supplements
Several randomized, controlled trials of less than 10 years duration report no association between several antioxidant
supplements (i.e., vitamin E, vitamin C, -carotene) and cognitive function or dementia development.
One large trial, including up to 1520 years of treatment with -carotene supplements, found that those assigned to -carotene
had significantly better cognitive function than those assigned to placebo. Thus, the duration of treatment may be a critical factor
in any potential neuroprotection from antioxidant vitamins.
Conclusions
Overall, the epidemiological literature indicates few cognitive benefits of antioxidant vitamins.
Specific data on antioxidants available in foods and on long-term use of antioxidant supplements demonstrate the most
promising results on brain aging.
Future perspective
Future studies will need to better focus on the role of diet on cognition, as well as the varying impacts of different durations of
antioxidant intake.
30
7.
8.
9.
10.
11.
12.
13.
vitamins, especially supplements, and the biological literature supports the hypothesis that
oxidative damage contributes to cognitive
impairment.
This focus on vitamin supplements is largely
due to the relative ease of collecting data on
supplements, compared with dietary habits.
Moreover, since long-term studies are difficult
to conduct and since data on long-term habits
are difficult to collect, most of the epidemiological investigations have explored overall use
of antioxidant supplements and cognition, and
have not examined the specific duration of
their use. Results from these studies have generally been inconclusive and do not strongly
indicate that antioxidant vitamin supplements
can reduce risk of cognitive impairments.
However, the most promising data regard the
potential of antioxidants in foods to lower rates
of cognitive aging, and the possibility that long
durations (i.e., >10 years) of antioxidant supplementation are required to provide
neuroprotection. Thus, important aspects of
future research on antioxidant vitamins and
dementia will include prospective studies that
have the ability to specifically explore antioxidant in the diet, as well as long-term
patterns of diet and supplementation.
www.futuremedicine.com
14.
15.
16.
17.
31
18.
19.
20.
21.
22.
23.
24.
25.
32
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.